Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A

5(31.3%)

Phase 2

5(31.3%)

Phase 4

3(18.8%)

Phase 1

2(12.5%)

Phase 3

1(6.3%)

16Total

N/A(5)

Phase 2(5)

Phase 4(3)

Phase 1(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT07393360Not ApplicableRecruiting

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Role: collaborator

NCT04705220Not ApplicableCompleted

Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome

Role: collaborator

NCT03227146Phase 2Active Not Recruiting

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

Role: collaborator

NCT02568826Phase 2Withdrawn

Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain

Role: collaborator

NCT06112535Not ApplicableCompleted

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery

Role: collaborator

NCT03229564Phase 2Active Not Recruiting

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

Role: collaborator

NCT04660721Phase 1Completed

A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery

Role: collaborator

NCT03394612Phase 2Active Not Recruiting

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

Role: collaborator

NCT02460458Completed

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

Role: collaborator

NCT03388255Phase 4Terminated

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Role: collaborator

NCT02067806Completed

Observational Study on 2-chloroprocaine Hydrochloride 1%

Role: collaborator

NCT04176328Phase 1Completed

Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients

Role: collaborator

NCT03942367Not ApplicableCompleted

Evaluation of the Safety and Effectiveness of the vPatch Device

Role: collaborator

NCT02973880Phase 3Completed

Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction

Role: collaborator

NCT01064284Phase 4Completed

Survey of Inhibitors in Plasma-Product Exposed Toddlers

Role: collaborator

NCT02851953Not ApplicableCompleted

Effectiveness and Safety Evaluation of Aqueduct -100 Device

Role: collaborator

NCT02479087Phase 4Unknown

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

Role: collaborator

NCT00727324Phase 2Completed

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Role: collaborator

All 18 trials loaded